Our study found that RGC32 had significant positive effects on this ATM/ATR/CHK1 pathway, so we speculated that the inhibition of DLBCL cells proliferation caused by inhibition of RGC32 partly depended on the inhibition of this pathway. The gene discussed is CHEK1; the disease is diffuse large B-cell lymphoma.